Apr 21, 2025 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario, April 21, 2025 — Sharp Therapeutics Corp. (“Sharp” or the “Company”) (TSX-V:SHRX), a pre-clinical-stage biotechnology company developing small molecule therapies to treat hereditary...
Jan 27, 2025 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(January 27, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (“Sharp” or the “Company”), a pre-clinical stage biotechnology company specializing in small molecule drugs to treat...
Jan 16, 2025 | Press Releases
Pittsburgh, Pennsylvania and Toronto, Ontario–(January 16, 2025) – Sharp Therapeutics Corp. (TSXV: SHRX) (“Sharp” or the “Company”), a pre-clinical stage biotechnology company specializing in small molecule drugs to treat genetic...
Dec 12, 2024 | Press Releases
Toronto, Ontario–(December 12, 2024) – Sharp Therapeutics Corp. (TSXV: EVP.P) (“Sharp Therapeutics”), formerly EVP Capital Inc. (“EVP Capital”), an Ontario corporation is pleased to announce the successful completion of its...
